RZGF(SZ:002629)2019-10-29 16:00Financial Performance - Operating revenue for the reporting period was CNY 21,010,121.47, a significant decline of 97.57% compared to the same period last year[7]. - Net profit attributable to shareholders of the listed company was a loss of CNY 6,755,813.99, an increase in loss of 52.00% year-on-year[7]. - Basic earnings per share were -CNY 0.02, a decrease of 33.33% year-on-year[7]. - The weighted average return on net assets was -30.94%, a decline of 28.83% compared to the previous year[7]. - Total operating revenue for the current period is 21,010,121.47, a significant decrease from 863,284,304.61 in the previous period[55]. - The net profit for the current period was a loss of ¥11,151,260.67, compared to a loss of ¥25,261,378.26 in the previous period, indicating an improvement[64]. - Total profit for the current period is -7,034,766.51, an improvement from -15,563,454.43 in the previous period[56]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 295,157,593.36, a decrease of 9.57% compared to the end of the previous year[7]. - Total liabilities increased due to the recognition of potential penalties and losses from overdue loans[15]. - The total owner's equity decreased from CNY 25,090,788.02 to CNY 13,811,470.14, a decline of approximately 45%[48]. - The company's total current assets decreased from CNY 94,742,967.15 to CNY 78,061,928.74, a reduction of about 17.7%[51]. - The total liabilities to total assets ratio stands at approximately 92.3%, indicating a high leverage level[82]. Cash Flow - The net cash flow from operating activities was a negative CNY 2,483,112.41, worsening by 74.31% compared to the same period last year[7]. - Cash and cash equivalents decreased by 72.36% compared to the beginning of the period, primarily due to the repayment of short-term loans[15]. - The ending cash and cash equivalents balance was 9,512,961.54 CNY, down from 34,017,835.26 CNY at the beginning of the period[73]. - The company reported a cash inflow from operating activities of ¥66,285,996.97 for the period[71]. - The net cash flow from investment activities was 7,744,471.40 CNY, showing an increase from the previous period[73]. Shareholder Information - Net assets attributable to shareholders of the listed company were CNY 13,931,023.07, down 44.74% year-on-year[7]. - The total number of ordinary shareholders at the end of the reporting period was 31,139[11]. - The largest shareholder, Tibet Hanlai Electronic Technology Partnership, held 19.76% of the shares, amounting to 81,387,013 shares[11]. Legal Matters - The company is involved in a lawsuit with Huzhou Maolian Machinery Equipment Co., Ltd. regarding a sales contract dispute, with a litigation amount of 78.5 million RMB, and the case has been heard but not yet decided[22]. - The company has filed lawsuits against Shanghai Suk Industrial Co., Ltd. and Luo Chengcai, with litigation amounts of 25.7437 million RMB and 37.9 million RMB respectively; the latter has received a first-instance judgment[23]. - The company’s wholly-owned subsidiary, Shanghai Hengdu, is involved in a lawsuit with Zhangjiagang Bonded Zone Hongdasheng International Trade Co., Ltd. over a sales contract dispute, with a litigation amount of 60 million RMB, and the case is still pending[24]. Management and Operational Changes - The company’s management expenses decreased by 58.10% year-on-year, reflecting ongoing structural adjustments[15]. - The company is planning a major asset restructuring involving the acquisition of 100% equity in Ningbo Keyuan Fine Chemical Co., Ltd., but the restructuring has been terminated due to risks and uncertainties[25]. - The company has not engaged in any significant new product development or market expansion strategies during the reporting period[41]. Research and Development - Research and development expenses decreased by 46.22% year-on-year, attributed to reduced investment in oil service business R&D projects[15]. - The company is investing in new technology development, allocating 100 million yuan towards R&D initiatives in the upcoming fiscal year[33]. - The company incurred research and development expenses of ¥1,106,877.48, down from ¥2,058,251.20 in the previous period[62].